Literature DB >> 907988

Role of heredity in multiple primary cancer.

H T Lynch, R E Harris, P M Lynch, H A Guirgis, J F Lynch, W A Bardawil.   

Abstract

The occurrence of multiple primary malignant neoplasms characterizes virtually all varieties of hereditary cancer. This report focuses on this phenomenon in 11 families with the Cancer Family Syndrome (heritable adenocarcinomas of the colon and endometrium) and a single extended kindred with site-specific colon cancer. Of the 316 relatives with cancer in the 12 families, 68 (21.5%) had two or more primary malignancies and 59 (86.8%) of these multiple primaries involved the colon and/or endometrium. A pooled analysis of this resource revealed a consistent 3% risk for a second primary cancer in each year of survival following first onset. If a second primary occurs, the risk for a third is extremely high (6.9% per year), but shows a nonlinear trend with increasing survival following second onset. The high risk for development of extraprimary malignancies in patients from these kindreds indicates that careful consideration should be given to total removal of their principal target organs following the initial manifestation of cancer.

Entities:  

Mesh:

Year:  1977        PMID: 907988     DOI: 10.1002/1097-0142(197710)40:4+<1849::aid-cncr2820400813>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.

Authors:  Andreas Obermair; Danny R Youlden; Joanne P Young; Noralane M Lindor; John A Baron; Polly Newcomb; Susan Parry; John L Hopper; Robert Haile; Mark A Jenkins
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

Review 2.  Lynch syndrome: clinical, pathological, and genetic insights.

Authors:  Ralph Schneider; Claudia Schneider; Matthias Kloor; Alois Fürst; Gabriela Möslein
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

3.  Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study.

Authors:  Hui-Yun Cheng; Cheng-Hsin Chu; Wen-Hsiung Chang; Tzu-Chi Hsu; Shee-Chan Lin; Chuan-Chuan Liu; An-Ming Yang; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 4.  The evolution of colorectal cancer genetics-Part 1: from discovery to practice.

Authors:  Andrew T Schlussel; Ronald A Gagliano; Susan Seto-Donlon; Faye Eggerding; Timothy Donlon; Jeffrey Berenberg; Henry T Lynch
Journal:  J Gastrointest Oncol       Date:  2014-10

5.  Features of ovarian cancer in Lynch syndrome (Review).

Authors:  Kanako Nakamura; Kouji Banno; Megumi Yanokura; Miho Iida; Masataka Adachi; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Hiroyuki Nomura; Akira Hirasawa; Eiichiro Tominaga; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-08-20

6.  A Case of Perimenopausal Endometrial Cancer in a Woman with MSH2 Germline Mutation.

Authors:  Eun Jin Heo; Jung Min Park; Eun Hee Lee; Hyoun Wook Lee; Min Kyu Kim
Journal:  J Menopausal Med       Date:  2013-12-27

7.  Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Authors:  Amanda S Bruegl; Bojana Djordjevic; Brittany Batte; Molly Daniels; Bryan Fellman; Diana Urbauer; Rajyalakshmi Luthra; Charlotte Sun; Karen H Lu; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-25

8.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Multiple primary malignant neoplasms in urologic patients.

Authors:  Osman Inci; Esat Kaya; Bulent Alagol; Irfan Huseyin Atakan; Sabahattin Aydin; Hasan Ereselli
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

10.  A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer.

Authors:  A J Greenstein; G Slater; T M Heimann; D B Sachar; A H Aufses
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.